CClinicalTrials.gg
CompletedNCT00912795SMS TurkeyUpdated Oct 5, 2016Results posted

SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation

An interventional study of SMS Turkey in Smoking, sponsored by Center for Innovative Public Health Research. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-10-05.

Sponsored by Center for Innovative Public Health Research · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
151
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to develop and test a text messaging-based smoking cessation program for adults who are currently smoking and want to quit, living in Turkey.

Read the detailed description

Smoking has long been recognized as a significant public health concern associated with great morbidity and mortality. Although smoking rates have decreased in high income countries, these trends have not been noted for tow and middle income countries. This is especially true in Turkey, which was ranked 6th in the world in smoking consumption. Between 51-63% of Turkish men and 24-26% of Turkish women 15 years of age and older are smokers. With lung cancer the leading cancer-related cause of death for both men and women, effective and accessible smoking cessation interventions are needed. Cell phone technology represents a unique opportunity to deliver evidenced-based smoking cessation behavioral treatments through a delivery mechanism already widely adopted by adults. An estimated 35 million Turks were using cell phones, making them 1.8 times more common than land lines. Cell phone interventions are a unique delivery method because of their 'always on' capability. The rapid uptake of cell phones allows us to potentially reach those who might otherwise not utilize smoking cessation services.

We designed and evaluated SMS Turkey, an evidenced-based smoking intervention that takes advantage of technologies adopted by adult smokers in Turkey. The primary outcome measure is sustained abstinence 12 weeks after quit day, confirmed with a carbon monoxide (CO) reading of 8 ppm or less. Sustained abstinence was defined as 5 or fewer cigarettes smoked since the quit date, per West et al. Secondary outcome measures included: 7-day and 30-day point prevalence of smoking behavior at 3 months; CO-verified 7-day point prevalence at 4 weeks; and reduction in cigarettes per day for those who are smoking at 3 months.

02

Conditions studied

  • Smoking

Keywords

  • Smoking Cessation
  • technology
  • developing countries
03

In context

Lead sponsor

Center for Innovative Public Health Research is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 18 years of age or older
  • Currently smoking every day
  • Owning a TXT-capable cell phone
  • Sent or received TXT messages at least once in the past year
  • Living in Ankara (to ease technology support if necessary)
  • Agreement to set quit day in 15 days from enrollment date
  • Agreement to verification of smoking cessation using a carbon monoxide breath monitor

Exclusion criteria

Exclusion Criteria:

  • No chronic disease.
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
151 participants (actual)

Study arms

  • Experimental
    SMS Turkey

    6-week smoking cessation program delivered via daily text messages

    Behavioral: SMS Turkey

  • No intervention
    Brochure control

    7-page brochure that provided general information and tips on how to quit smoking

Interventions

  • BehavioralSMS Turkey

    6-week smoking cessation program delivered via daily text messages SMS Turkey: 6-week smoking cessation program delivered via text messaging. SMS Turkey content is guided by the Cognitive Behavioral Therapy (CBT) theory. Content was tailored based on participant's stage in quitting (i.e., pre-quit, quit day, early-quit, late-quit, relapse). Based on the typical relapse trajectory, content paths were created for participants based on whether or not they were smoking 2 days after quit day; and again at 7 days after quit day. Depending on the participant's content path, the total number of messages received ranged from 91 (for those assigned to the encouragement arm) to 146 (for those who relapsed and then were assigned to the late quit messages).

    Also known as: Cebiniz birakin diyor

06

What researchers measure

Primary outcomes

  1. Carbon Monoxide-verified Continuous Abstinence at 12 Weeks

    self-reported continuous abstinence since quit day (\<=5 cigarettes) verified with carbon monoxide reading (\<=8ppm)

    Time frame: 12-weeks post-quit day

Secondary outcomes

  1. CO-verified 7-day Point Prevalence Abstinence at 4 Weeks

    self-reported continuous abstinence in the past 7 days at 4 weeks (\<=5 cigarettes) verified with carbon monoxide reading (\<=8ppm)

    Time frame: 4 weeks

  2. Self-reported 7-day Point Prevalence Abstinence at 12 Weeks

    self-reported smoking abstinence in the past 7 days at 12 weeks (\<=5 cigarettes)

    Time frame: 12 weeks

  3. Self-reported 30-day Point Prevalence Abstinence at 12 Weeks

    self-reported smoking abstinence in the past 30 days at 12 weeks (\<=5 cigarettes)

    Time frame: 12 weeks

07

Results

Posted Oct 5, 2016
Limitations and caveats
An imbalance favoring the intervention was detected after approximately 100 participants were enrolled. To ensure a 1:1 match, the procedure was modified so that the RA pulled a slip of paper from a hat that read either "SMS Turkey" or "brochure."

Participant flow

Participants were recruited in Ankara, Turkey between December 2010 \& June 2011, through in-person outreach at local shopping malls and local newspapers advertisements. Flyers were also posted at Hacettepe University. Smokers indicated their interest by calling the study office or speaking directly with the research assistant at the shopping mall.

Participant flow — Overall Study
MilestoneSMS TurkeyBrochure Control
Started7675
Completed2917
Not completed4758

Outcome measures

PrimaryCarbon Monoxide-verified Continuous Abstinence at 12 Weeks

self-reported continuous abstinence since quit day (\<=5 cigarettes) verified with carbon monoxide reading (\<=8ppm)

Time frame:
12-weeks post-quit day
Reported as:
Number · participants
Carbon Monoxide-verified Continuous Abstinence at 12 Weeks
participantsSMS TurkeyBrochure Control
Carbon Monoxide-verified Continuous Abstinence at 12 Weeks84
Statistical analysis
  • SMS Turkey vs Brochure Control · Risk ratio (rr): 2.0 · 95% CI 0.62 to 6.3
SecondaryCO-verified 7-day Point Prevalence Abstinence at 4 Weeks

self-reported continuous abstinence in the past 7 days at 4 weeks (\<=5 cigarettes) verified with carbon monoxide reading (\<=8ppm)

Time frame:
4 weeks
Reported as:
Number · participants
CO-verified 7-day Point Prevalence Abstinence at 4 Weeks
participantsSMS TurkeyBrochure Control
CO-verified 7-day Point Prevalence Abstinence at 4 Weeks97
Statistical analysis
  • SMS Turkey vs Brochure Control · Risk ratio (rr): 1.3 · 95% CI 0.50 to 3.2
SecondarySelf-reported 7-day Point Prevalence Abstinence at 12 Weeks

self-reported smoking abstinence in the past 7 days at 12 weeks (\<=5 cigarettes)

Time frame:
12 weeks
Reported as:
Number · participants
Self-reported 7-day Point Prevalence Abstinence at 12 Weeks
participantsSMS TurkeyBrochure Control
Self-reported 7-day Point Prevalence Abstinence at 12 Weeks104
Statistical analysis
  • SMS Turkey vs Brochure Control · Risk ratio (rr): 2.5 · 95% CI 0.81 to 7.5
SecondarySelf-reported 30-day Point Prevalence Abstinence at 12 Weeks

self-reported smoking abstinence in the past 30 days at 12 weeks (\<=5 cigarettes)

Time frame:
12 weeks
Reported as:
Number · participants
Self-reported 30-day Point Prevalence Abstinence at 12 Weeks
participantsSMS TurkeyBrochure Control
Self-reported 30-day Point Prevalence Abstinence at 12 Weeks84
Statistical analysis
  • SMS Turkey vs Brochure Control · Risk ratio (rr): 2.0 · 95% CI .62 to 6.3

Adverse events

Collected over Adverse event data were collected through the study period (i.e., from baseline to 12-week follow-up).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
SMS Turkey—0/76 (0%)0/76 (0%)
Brochure Control—0/75 (0%)0/75 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)SMS TurkeyBrochure ControlTotal
Mean35.6 ± 10.336.1 ± 9.535.89 ± 9.89
Sex: Female, Male
Sex: Female, Male(Participants)SMS TurkeyBrochure ControlTotal
Female352459
Male415192
Income
Income(participants)SMS TurkeyBrochure ControlTotal
Less than 2000 Turkish lira per month233760
2000 - 4000 Turkish lira per month342862
More than 4000 Turkish lira per month16925
Do not want to answer314
Martial status
Martial status(participants)SMS TurkeyBrochure ControlTotal
Married424991
Single302555
Divorced404
Widowed011
Educational attainment
Educational attainment(participants)SMS TurkeyBrochure ControlTotal
High school or less283866
Two-year college131023
University degree272350
Post graduate degree8412
Average Number of cigarettes smoked per day
Average Number of cigarettes smoked per day(number of cigarettes per day)SMS TurkeyBrochure ControlTotal
Mean18.7 ± 7.220.4 ± 9.219.53 ± 8.27
Age at first cigarette
Age at first cigarette(years)SMS TurkeyBrochure ControlTotal
Mean17.5 ± 3.717.1 ± 3.617.3 ± 3.6
Fagerström score
Fagerström score(score)SMS TurkeyBrochure ControlTotal
Mean4.8 ± 2.34.9 ± 2.54.8 ± 2.4

3 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Hacettepe University
    Ankara, Turkey
09

References and documents

Publications

  • Ybarra ML, Bagci Bosi AT, Bilir N, Holtrop JS, Korchmaros J, Emri S. Interest in technology-based and traditional smoking cessation programs among adult smokers in Ankara, Turkey. Tob Induc Dis. 2011 Aug 1;9(1):10. doi: 10.1186/1617-9625-9-10. PubMed 21806793 ↗
  • Ybarra ML, Holtrop JS, Bagci Bosi AT, Emri S. Design considerations in developing a text messaging program aimed at smoking cessation. J Med Internet Res. 2012 Jul 24;14(4):e103. doi: 10.2196/jmir.2061. PubMed 22832182 ↗
  • Ybarra M, Bagci Bosi AT, Korchmaros J, Emri S. A text messaging-based smoking cessation program for adult smokers: randomized controlled trial. J Med Internet Res. 2012 Dec 27;14(6):e172. doi: 10.2196/jmir.2231. Erratum In: J Med Internet Res. 2015 Jun 05;17(6):e125. doi: 10.2196/jmir.4655. PubMed 23271159 ↗
  • Ybarra ML, Holtrop JS, Bagci Bosi AT, Bilir N, Korchmaros JD, Salih Emri AK. Feasibility and acceptability of a text messaging-based smoking cessation program in ankara, Turkey. J Health Commun. 2013 Aug;18(8):960-73. doi: 10.1080/10810730.2012.757399. Epub 2013 Apr 29. PubMed 23627304 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00912795
Lead sponsor
Center for Innovative Public Health Research
Collaborators
Hacettepe University, Fogarty International Center of the National Institute of Health
Responsible party
Sponsor
First posted
Jun 3, 2009
Start date
Dec 2010
Primary completion
Sep 2011
Completion
Sep 2011
Results posted
Oct 5, 2016
Last update
Oct 5, 2016

Study contacts

Michele Ybarra, MPH PhD
principal investigator · Center for Innovative Public Health Research

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion